Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06358404 · ClinicalTrials.gov registry record · NA

Developing a Peer Support Intervention for Depression in SCD

A NA study of Subjective Cognitive Decline and Depression in Old Age, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06358404: Recruiting NA study of Subjective Cognitive Decline and Depression in Old Age, sponsored by Massachusetts General Hospital.

NCT06358404 is a NA study of Subjective Cognitive Decline and Depression in Old Age that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 30 participants, below the 80-participant average among 6 other Subjective Cognitive Decline trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06358404, a NA study of Subjective Cognitive Decline and Depression in Old Age, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the feasibility, acceptability, and fidelity of an 8-week intervention where peer coaches will deliver depression care to adults 60 years of age or older who have depression and subjective cognitive decline.

Primary Outcome

Level of participant engagement: how many screened older adults agree to participate in the intervention and complete baseline assessments

Interventions

  • BEHAVIORAL PeersCOG

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-05-01
Est. Completion 2026-04-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06358404 shows while recruiting

NCT06358404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 80-participant average among 6 other Subjective Cognitive Decline trials with a reported enrollment target (62% lower).

The record links to 2 conditions, with Subjective Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which PeersCOG is the first listed.

NCT06358404 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06358404 about?

NCT06358404 is a clinical study titled "Developing a Peer Support Intervention for Depression in SCD". The purpose of this study is to assess the feasibility, acceptability, and fidelity of an 8-week intervention where peer coaches will deliver depression care to adults 60 years of age or older who have depression and subjective cognitive decline.

What is the current status of trial NCT06358404?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-01. Estimated completion is 2026-04-30.

What conditions does trial NCT06358404 study?

This clinical trial studies the following conditions: Subjective Cognitive Decline, Depression in Old Age.

What interventions are being tested in trial NCT06358404?

The interventions under investigation include: PeersCOG (BEHAVIORAL).

Who is sponsoring clinical trial NCT06358404?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06358404 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Subjective Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06358404, the US trial registry maintained by the National Library of Medicine. NCT06358404 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.